Aug 11
|
IBAT Inhibitors Market Witnesses Strong Growth During the Forecast Period (2025-2034) Owing to the Rising Demand for Rare Cholestatic Liver Disease Therapies | DelveInsight
|
Aug 11
|
GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic
|
Aug 8
|
BioNTech (BNTX) Settles mRNA Patent Dispute with CureVac for US$370 Million
|
Aug 8
|
GILD Stock Rises on Q2 Earnings and Sales Beat, '25 View Up
|
Aug 8
|
Trending tickers: Nvidia, Intel, The Trade Desk, Pinterest and GSK
|
Aug 8
|
GSK to Receive $370 Million in U.S. Patent Litigation Settlement
|
Aug 7
|
Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma
|
Aug 5
|
[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
|
Aug 4
|
GILD Likely to Beat on Q2 Earnings: Buy, Sell or Hold the Stock?
|
Aug 1
|
Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices
|
Aug 1
|
India's GlaxoSmithKline Pharma posts first revenue drop in over two years
|
Aug 1
|
Analysts Have Made A Financial Statement On GSK plc's (LON:GSK) Interim Report
|
Aug 1
|
The 'cheapest' stocks on FTSE 100 as UK blue-chip index trades at record high
|
Jul 31
|
What Trump's Big Pharma CEO letters mean for drug pricing power
|
Jul 31
|
Company News for Jul 31, 2025
|
Jul 31
|
Chicken Pox Market Analysis and Forecast 2025-2035 | Varicella Vaccine Demand Soars as Global Health Initiatives Expand
|
Jul 30
|
FTSE 100 ends flat ahead of likely US rate hold
|
Jul 30
|
GSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise
|
Jul 30
|
GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth
|
Jul 30
|
GSK reports improved outlook despite US drug tariffs
|